Haitian C. Fu
No. 1000, Hefeng Road
Wuxi, 214000, China
Wuxi, 214000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers.
Journal: Journal of medicinal chemistry
Published: March 24, 2026
A Preclinical Study of [64Cu]Cu-NOTA-KN035 for Molecular Imaging of PD-L1 in Tumors.
Journal: Molecular pharmaceutics
Published: February 19, 2026
Rational Design and Preliminary Evaluation of a Radiopharmaceutical Targeting Fibroblast Activation Proteins [68Ga]Ga/[177Lu]Lu-FAPI-JNU for Tumor Imaging and Therapy.
Journal: Journal of medicinal chemistry
Published: June 11, 2025
Noninvasive Imaging of Claudin 18.2 Expression in Gastric Adenocarcinoma: Synthesis, Preclinical Evaluation, and Preliminary Clinical Study of a Novel [89Zr]Zr-DFO-NY005 Immuno-Positron Emission Tomography Tracer.
Journal: International journal of radiation oncology, biology, physics
Published: April 23, 2025
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy.
Journal: Frontiers in pharmacology
Published: March 14, 2025
PSMA-targeted radioligand therapy with [177Lu]Lu-LNC1011 for metastatic castration-resistant prostate cancer: a pilot study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 23, 2025
Preclinical Evaluation of a Novel PSMA-Targeted Agent 68Ga-NOTA-GC-PSMA for Prostate Cancer Imaging.
Preclinical Evaluation of a Novel PSMA-Targeted Agent 68Ga-NOTA-GC-PSMA for Prostate Cancer Imaging.
Journal: Tomography (Ann Arbor, Mich.)
Published: January 19, 2025
Homocysteine interferes with Ndufa1 leading to mitochondrial dysfunction through repression of the NAD+/Sirt1 pathway in the brain: a possible link between hyperhomocysteinemia and neurodegeneration.
Journal: Cell death & disease
Published: November 29, 2024
Development and preclinical evaluation of a cyclic PET tracer targeting integrin-α6 on colorectal cancer models.
Journal: Bioorganic chemistry
Published: September 18, 2024
Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 08, 2024
Value of [68Ga]Ga-NYM046 PET/CT, in Comparison with 18F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 31, 2024
A novel PSMA targeted dual-function near-infrared fluorescence and PET probe for the image-guided surgery and detection of prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 22, 2023
Last Updated: 09/26/2026